6533b830fe1ef96bd1297222
RESEARCH PRODUCT
First clinical results with a new telemetric intracranial pressure-monitoring system.
Christoph A. TschanPhilippe DodierSonja VulcuJoachim OertelWolfgang WagnerEva SchmalhausenStefan Welscheholdsubject
VentriculostomyAdultMalemedicine.medical_specialtyAdolescentPseudotumor cerebrimedicine.medical_treatmentYoung AdultIntensive careTransducers PressureMedicineHumansTelemetryProspective StudiesChildIntracranial pressureMonitoring Physiologicmedicine.diagnostic_testbusiness.industryEndoscopic third ventriculostomyMiddle Agedmedicine.diseaseHydrocephalusEndoscopyChild PreschoolIntracranial pressure monitoringSurgeryFemaleNeurology (clinical)RadiologyIntracranial Hypertensionbusinessdescription
Background The knowledge of intracranial pressure (ICP) is the basis of an appropriate neurosurgical treatment. Because clinical, fundoscopic, or radiological data alone are often elusive, a pre- or postoperative long-term monitoring of the ICP itself is desirable. Objective We describe the first clinical experiences with a new telemetric ICP-monitoring device. Methods The transducer of this telemetric intraparenchymal pressure probe is placed under the galea over the calvaria. ICP can be monitored via a special telemetric reader, placed over the intact skin, and the ICP values are stored in a small portable computer. The system does not require an intensive care environment and can be used in any ward or even at home. The system was successfully applied in 10 patients (age, 3-56 years) in whom raised ICP due to hydrocephalus, shunt dysfunction, endoscopic third ventriculostomy failure, craniostenosis, or pseudotumor cerebri was suspected. Results Continuous telemetric monitoring of ICP was performed for 2 to 24 weeks. In 7 patients, increased ICP values could be excluded, and further surgical maneuvers were avoided. In 3 patients, repeated plateaus or continuously raised ICP indicated surgery resulting in a normalization of ICP. Conclusion This new telemetric system was safe and effective for ICP measurement over a long period, including home monitoring. For the patients, it was easy to handle, and reliable data could be recorded over many weeks. Based on this preliminary experience, the authors consider the new system extremely advantageous in surgical decision making in particularly difficult cases of suspected abnormalities of ICP.
year | journal | country | edition | language |
---|---|---|---|---|
2011-07-21 | Neurosurgery |